people

• Overview
• Grant Central
• Medvane
• Profiles

learning

• Overview
• Colloquium Series
• Conferences and Seminars
• Dean's Symposium
• Leder Human Biology
• Biomedical Informatics Training
• Biostatistics Training
• Clinical Investigator Training Program
• Scholars in Clinical Science
• KL2 Medical Research Investigator Training
• Introduction to Clinical Investigation
• Biostatistics Seminar Series
• Genetics Courses
• Imaging Courses

resources

• Overview
• Pilot Funding
• AEGIS Influenza
• Atlas
• Community-Based Participatory Research
• Community Connect to Research
• Consulting Programs
• Core Facilities
• HarvardTrials
• Health Disparities Research Program
• In/Outpatient Resources
• Laboratory for Innovative Translational Technologies
• Law and Health Policy
• Medications and Society
• Pathology Specimen Locator
• SHRINE
• Webdash

Harvard Catalyst Member Profile: Randy Gollub, M.D., Ph.D.

April 8, 2009

In her role as co-director of the Harvard Catalyst Imaging Consortium, Dr. Randy Gollub is working with imaging experts across Harvard to provide counsel and education to the Harvard Catalyst community on the use of imaging technologies like CT, PET, and MRI in translational research. Dr. Gollub is the Associate Director of Psychiatric Neuroimaging research at Massachusetts General Hospital and Director of the Center for Biomedical Imaging, a core facility supported by Harvard Catalyst located within Massachusetts General Hospital’s Martinos Center for Biomedical Imaging. She is an Associate Professor of Psychiatry at Harvard Medical School. Her own research focuses on the use of biomedical imaging to understand the neural mechanisms of pain perception and how expectations affect that perception and ultimately influence response to treatment. The long-term goal of her work is to advance biomedical imaging technologies so that imaging can be used for diagnosis, prognosis, and treatment response in individual patients suffering from neuropsychiatric disorders.

“The spatial and temporal resolution of imaging technologies are increasing at an accelerating pace,” she said, “putting at our fingertips ever more powerful means of peering into and understanding the mechanisms of health, disease, and the treatment of disease. Our collaborating sites have long been leaders in this field. What we in the Imaging Consortium bring to Harvard Catalyst is a deep knowledge of the current capabilities of biomedical imaging, as well as the desire to expand those capabilities in ways that facilitate cutting-edge translational research. We look forward to working with both imaging experts and imaging novices to help them design studies, acquire, analyze, and interpret imaging data in ways that help them achieve their research objectives. We are particularly delighted that Harvard Catalyst is lowering the barriers for using cross-institutional solutions to achieve the best outcome for clinical translational scientists.”

One way in which the Harvard Catalyst Imaging Consortium works with the Harvard affiliated community is through a consultation service that helps investigators incorporate the most advanced and appropriate imaging technologies and analyses into their research projects through a combination of information sharing, networking, and guidance on technical and regulatory issues. The Consortium also works to integrate medical imaging informatics with the world-class bioinformatics programs of the partnering institutions in order to extend the uses of clinical and research imaging data. The Consortium is also developing a series of comprehensive educational offerings aimed at teaching clinicians and researchers the fundamentals and applications of medical imaging.